NetworkNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp.'s Delivery Systems Creating Viable Alternatives for Nicotine Consumption
New York, New York--(Newsfile Corp. - January 23, 2019) - NetworkNewsAudio announces the Audio Press Release (APR) titled "Definitive Agreement Marks Milestone for Alternative Nicotine Delivery Options," featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP).
To hear the NetworkNewsAudio version, visit: http://nnw.fm/Kft8h
To read the full editorial, visit: http://nnw.fm/xbD2Z
The bioscience potential for nicotine delivery cannot be ignored, but this strategic partnership is about more than big money for big innovations. Rather, the creation of alternative delivery systems for nicotine is rooted in helping people kick the smoking habit and removing the risk of lung cancer and the impact of passive smoking on those around them. The aim of the agreement is to create a more socially acceptable and less disruptive way to consume nicotine.
The agreement between Lexaria and a Big Tobacco company has the potential to be a longer-term relationship. Lexaria Bioscience will at first retain a majority interest in Lexaria Nicotine. But Lexaria's new investor has the option to acquire 100 percent ownership interest in Lexaria Nicotine commensurate with then-current fair market value. And Lexaria Bioscience has not sold any of its own equity to its partner, remaining fully independent. With favorable research results, such an outcome could set up the tobacco company a new way forward in tobacco products while providing Lexaria Bioscience with significant additional financial resources to fund growth in its hemp/CBD, pharmaceutical and other divisions.
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and quicker onset of lipophilic active molecules. Lexaria has ten patents granted in the USA and in Australia and has filed over 50 patent applications worldwide across ten patent families. Lexaria's technology provides more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria Nicotine LLC is a United States domiciled, majority-owned subsidiary of Lexaria Bioscience Corp., focused on reduced-risk nicotine solutions www.LexariaNicotineco.com. For more information, visit the company's website at www.LexariaBioscience.com.
NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) can assist your company by cutting through the overload of information in today's market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.
For more information, visit: www.NetworkNewsAudio.com
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Corporate Communications Contact: